46 results on '"Legido‐Quigley, Cristina"'
Search Results
2. Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN‐derived networks and highlights causal links in Alzheimer's disease
3. APOE ε4 alters docosahexaenoic acid's influence on preclinical markers of Alzheimer disease
4. Inflammatory biomarkers in Alzheimer's disease plasma
5. Replication study of plasma proteins relating to Alzheimer's pathology
6. Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post‐hoc analysis of a randomized crossover trial
7. Identification of plasma proteome signatures associated with ATN framework using SOMAscan
8. Association of TREM2 variants and sphingolipid levels with AD in blood and brain
9. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
10. O5‐05‐03: ASSOCIATIONS BETWEEN CEREBROSPINAL FLUID NEURODEGENERATIVE MARKERS, NEUROFILAMENT‐LIGHT AND TOTAL TAU AND CEREBROVASCULAR IMAGING MARKERS
11. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
12. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
13. A metabolite‐based machine learning approach to diagnose Alzheimer‐type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
14. F1‐02‐03: MRI PREDICTORS OF AMYLOID PATHOLOGY: RESULTS FROM THE EMIF‐AD BIOMARKER DISCOVERY STUDY
15. F1‐02‐02: DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN AND ALZHEIMER'S DISEASE PROGRESSION
16. F1‐02‐01: RELATING CSF MARKERS NEUROGRANIN, NEUROFILAMENT‐LIGHT AND YKL‐40 TO Aβ, APOE ε4 AND COGNITION: RESULTS FROM THE EMIF‐AD MULTIMODAL BIOMARKER DISCOVERY STUDY
17. P3‐233: PLASMA PRIMARY FATTY AMIDES ASSOCIATE TO CSF AMYLOID LEVELS AND ALZHEIMER'S DISEASE PROGRESSION IN THE EMIF‐AD BIOMARKER DISCOVERY COHORT
18. P1‐235: SEX‐SPECIFIC ASSOCIATIONS OF SERUM BILE ACIDS WITH BRAIN ATROPHY DURING AGING: DIFFERENTIAL EFFECTS OF CONJUGATION AND GUT MICROBIAL METABOLISM
19. P2‐458: PREDICTING COGNITIVE DECLINE THROUGH STRUCTURAL MRI BIOMARKERS: RESULTS FROM THE EMIF‐AD BIOMARKER DISCOVERY STUDY
20. P2‐276: BRAIN AND BLOOD OXYSTEROL METABOLISM ARE RELATED TO ALZHEIMER'S DISEASE PATHOGENESIS
21. Evidence for brain glucose dysregulation in Alzheimer's disease
22. [P3-166]: NEUROTRANSMITTER-SPECIFIC METABOLISM IS RELATED TO SEVERITY OF PATHOLOGY AND SYMPTOM EXPRESSION IN ALZHEIMER's DISEASE
23. [P2-212]: EUROPEAN MEDICAL INFORMATION FRAMEWORK FOR ALZHEIMER's DISEASE (EMIF-AD): THE BIOMARKER DISCOVERY STUDY
24. DISCOVERY AND VALIDATION OF MULTIMODAL BIOMARKER SIGNATURES RELATING TO ALZHEIMER'S DISEASE PATHOLOGY AND PROGRESSION
25. [P1-289]: DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN (CSF Aβ OR AMYLOID-PET) IN THE EMIF-AD BIOMARKER DISCOVERY COHORT
26. [P3-207]: THE ENDOPHENOTYPE ASSOCIATION SCORE IN EARLY ALZHEIMER's DISEASE (EASE-AD): DISCOVERING NOVEL BLOOD AND BRAIN METABOLITE SIGNATURES OF PATHOLOGY AND PROGRESSION
27. Metabolic network failures in Alzheimer's disease: A biochemical road map
28. Peril beyond the winner's curse: A small sample size is the bane of biomarker discovery
29. Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis
30. F1-02-04: Plasma Phosphatidylcholines are Associated with Alzheimer's Disease as Well as Brain Function and Cognitive Performance During Aging
31. Assessment of Polygonum capitatum Buch.‐Ham. ex D.Don by metabolomics based on gas chromatography with mass spectrometry
32. Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals
33. Systematic evaluation of acetone and acetonitrile for use in hydrophilic interaction liquid chromatography coupled with electrospray ionization mass spectrometry of basic small molecules
34. Bile UPLC‐MS fingerprinting and bile acid fluxes during human liver transplantation
35. Evaluation of Chinese medicinal herbs fingerprinting by HPLC-DAD for the detection of toxic aristolochic acids
36. Chemometric and biological validation of a capillary electrophoresis metabolomic experiment of Schistosoma mansoni infection in mice
37. Chemometric analysis of urine fingerprints acquired by liquid chromatography-mass spectrometry and capillary electrophoresis: Application to the schistosomiasis mouse model
38. Liquid chromatography-mass spectrometry methods for urinary biomarker detection in metabonomic studies with application to nutritional studies
39. A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease
40. The autocorrelation matrix probing biochemical relationships after metabolic fingerprinting with CE
41. Advances in separation science applied to metabonomics
42. Fingerprinting of human bile during liver transplantation by capillary electrophoresis
43. Metabolic fingerprinting of Schistosoma mansoni infection in mice urine with capillary electrophoresis
44. Assessment of Chinese medicinal herb metabolite profiles by UPLC‐MS‐based methodology for the detection of aristolochic acids
45. Advances in capillary electrochromatography and micro‐high performance liquid chromatography monolithic columns for separation science
46. Liquid chromatography-mass spectrometry methods for urinary biomarker detection in metabonomic studies with application to nutritional studies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.